project-idea
RP1 oncolytic virus induces two molecularly distinct CD8+ T cell populations — progenitor-like precursors and terminal effectors — and a precursor-associated gene signature correlates with clinical response to RP1 plus PD-1 blockade in real melanoma patients, making this a candidate predictive…
project-idea
Four morphological classes of pancreatic cancer (glandular, cribriform, solid, squamous) each have distinct transcriptomic programs and clinical implications — meaning what a pathologist sees under a microscope encodes actionable molecular information that could guide treatment decisions without…
project-idea
KRAS inhibitors showed dramatic efficacy in appendiceal adenocarcinoma — a rare cancer with almost no approved treatments — and six real patients with heavily pre-treated disease responded, demonstrating that KRAS-mutant rare cancers outside the mainstream (colon, lung, pancreatic) may be…
project-idea
POU2F1 acts as the master transcriptional activator of DLL3 in SCLC — meaning DLL3 expression levels, which determine whether patients respond to DLL3-targeted therapies like tarlatamab, are now mechanistically explainable and potentially predictable from upstream transcription factor activity.
project-idea
FDA-approved SSRIs synergize with CDK9 inhibitors to kill diffuse midline glioma cells — meaning drugs that are safe, cheap, brain-penetrant, and already FDA-approved may have immediate translational potential in a childhood brain cancer with no effective treatments.
project-idea
This study created the first humanized ossicle model that faithfully reproduces myelofibrosis features including reticulin fibrosis and osteosclerosis, and identified SPP1 as a new therapeutic target — highlighting both a model gap and a drug target gap that a structured resource could help address.
project-idea
BRCA1/2 mutations in lung adenocarcinoma predict better responses to immune checkpoint blockade despite worse overall prognosis — creating a paradox that clinicians need tools to navigate when making immunotherapy decisions for NSCLC patients.
project-idea
Transformed breast cells use physical nanotube connections to transmit BMP signaling to normal neighbors, actively spreading a preneoplastic state — meaning early cancer initiation may be a contagious process, not just isolated mutations.
project-idea
When PI3K is blocked in AML cells, the cancer compensates by upregulating EZH1 — an escape route that can be closed by combining PI3K inhibitors with EZH1/2 dual inhibitors. This research makes a compelling case for systematically mapping known resistance bypass routes and their combination therapy…
colorectal-cancer
The idea that tumors harbor their own communities of microbes has gained attention in recent years. This large study — analyzing DNA from over 9,000 patients — found something surprising: while many cancers have been proposed to have their own microbial signatures, only colorectal cancer…
brain-cancer
Glioblastoma (GBM) is one of the most lethal cancers, in part because it co-opts its surrounding environment to support its own growth. A Canadian research team found that certain brain cells — previously thought to only support healthy neurons — can actually promote glioblastoma growth by sending…
blood-cancer
BET inhibitors (drugs targeting BET bromodomain proteins) showed extraordinary promise in early cancer research — they could suppress the expression of potent oncogenes like MYC. But clinical trials have repeatedly disappointed, with patients not responding as expected. A new study may have found…
